- Tetracyclines,
- Penicillins,
- Sulfonamides,
- Macrolides,
- Aminoglycosides,
- Lincosamides,
- Fluoroquinolones,
- Cephalosporins and Other Antimicrobials and
- Antibiotics
Animal Antibiotics and Antimicrobials Market size was valued at USD 4,561.3 million in 2021. It is expected to reach a value of USD 6,083.6 million by 2028, growing at a CAGR of 4.2% from 2022 to 2028. The global market provides a detailed overview of the animal antibiotics and antimicrobials market, which can be segmented by product type, mode of delivery, and animal type. By product type, the animal antibiotics and antimicrobials market has been segmented into tetracyclines, penicillin, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. The penicillins segment is likely to be the largest and fastest-growing segment in terms of product type. Based on mode of delivery, the animal antibiotics and antimicrobials market is segmented into premixes, oral powder, oral solution, injection, and others. Among these, the premixes segment is expected to have the fastest-growing market during the forecast period 2022-2028. Based on animal type, the market is segregated into food-producing animals and companion animals. The food-producing animal segment held a considerable market share during the forecast period. Key Developments: In Jul 2020, Zoetis collaborated with Trianni, Inc to build transgenic monoclonal antibody platforms to develop novel veterinary therapeutics. Â
Animal Antibiotics And Antimicrobials Market Summary
Study Period
2023-29
Base Year
2022
CAGR
4.2%
Largest Market
Asia Pacific
Fastest Growing Market
North America
Animal Antibiotics and Antimicrobials Market Drivers
Pet insurance increases primarily due to the increased cost of veterinarian services and treatments, increased demand for cattle-related items, and growth due to increased public awareness of various animal diseases are some key factors fostering the market growth.
North-America Got Significant Share
Animal Antibiotics and Antimicrobials Market
The North American market is expected to witness the highest market share during the forecast period. This region's substantial contribution is mainly related to its expanding animal population, rising demand for animal-based commodities, development of pet insurance, and spending higher than average costs for animal health care. The Asia-Pacific market expanded significantly during the anticipated period. The demand for animal antimicrobials has increased, and there are more animals, all of which are contributing reasons to the expansion of this industry.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The animal antibiotics and antimicrobials market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
- The animal antibiotics and antimicrobials market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The animal antibiotics and antimicrobials market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The animal antibiotics and antimicrobials market report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The animal antibiotics and antimicrobials market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Animal Antibiotics And Antimicrobials Market Segmentation
By Product Type
By Mode of Delivery
- Premixes,
- Oral Powder,
- Oral Solution,
- Injection and
- Others
By Animal Type
- Food-Producing Animals,
- Companion Animals
Frequently Asked Questions
The animal antibiotics and antimicrobials market is projected to expand at a CAGR of 4.2% during the forecast period.
The major players in the global animal antibiotics and antimicrobials market are Boehringer Ingelheim (Germany), Zoetis Inc. (US), Elanco Animal Health (US), Merck & Co. Inc (US), Phibro Animal Health (US), Virbac (France), Vetoquinol S.A. (France), Ceva Santé Animale (France), Dechra Pharmaceuticals Plc (UK) and Kyoritsu Seiyaku (Japan).
North America is the fastest-growing region for animal antibiotics and antimicrobials market
| 1. Executive Summary |
| 2. Global Animal Antibiotics and Antimicrobials Market Introduction |
| 2.1. Global Animal Antibiotics and Antimicrobials Market – Taxonomy |
| 2.2. Global Animal Antibiotics and Antimicrobials Market –Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Mode of Delivery |
| 2.2.3. By Animal Type |
| 2.2.4. By Region |
| 3. Global Animal Antibiotics and Antimicrobials Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Animal Antibiotics and Antimicrobials Market Dynamic Factors - Impact Analysis |
| 3.6. Global Animal Antibiotics and Antimicrobials Market – Competition Landscape |
| 4. Global Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Animal Antibiotics and Antimicrobials Market, By Product Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1. Tetracyclines |
| 5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Penicillins |
| 5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Sulfonamides |
| 5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Macrolides |
| 5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Aminoglycosides |
| 5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Â Lincosamides |
| 5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Fluoroquinolones |
| 5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 5.8. Cephalosporins |
| 5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.8.3. Market Opportunity Analysis |
| 5.9. Other Antimicrobials and Antibiotics |
| 5.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.9.3. Market Opportunity Analysis |
| 6. Global Animal Antibiotics and Antimicrobials Market, By Mode of Delivery, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1. Premixes |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Oral Powder |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Oral Solution |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Injection |
| 6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Animal Antibiotics and Antimicrobials Market, By Animal Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1. Food Processing Animals |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Companion Animals |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Animal Antibiotics and Antimicrobials Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Region, 2022-2028 |
| 9. North America Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 9.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Tetracyclines |
| 9.1.2. Penicillins |
| 9.1.3. Sulfonamides |
| 9.1.4. Macrolides |
| 9.1.5. Aminoglycosides |
| 9.1.6. Lincosamides |
| 9.1.7. Fluoroquinolones |
| 9.1.8. Cephalosporins |
| 9.1.9. Â Other Antimicrobials and Antibiotics |
| 9.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Premixes |
| 9.2.2. Oral Powder |
| 9.2.3. Oral Solution |
| 9.2.4. Injection |
| 9.2.5. Others |
| 9.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Food-Producing Animals |
| 9.3.2. Companion Animals |
| 9.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028 |
| 9.6. North America Animal Antibiotics and Antimicrobials Market Dynamics – Trends |
| 10. Europe Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Tetracyclines |
| 10.1.2. Penicillins |
| 10.1.3. Sulfonamides |
| 10.1.4. Macrolides |
| 10.1.5. Aminoglycosides |
| 10.1.6. Lincosamides |
| 10.1.7. Fluoroquinolones |
| 10.1.8. Cephalosporins |
| 10.1.9. Â Other Antimicrobials and Antibiotics |
| 10.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Premixes |
| 10.2.2. Oral Powder |
| 10.2.3. Oral Solution |
| 10.2.4. Injection |
| 10.2.5. Others |
| 10.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Food-Producing Animals |
| 10.3.2. Companion Animals |
| 10.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Rest of Europe |
| 10.5. Europe Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028 |
| 10.6. Europe Animal Antibiotics and Antimicrobials Market Dynamics – Trends |
| 11. Asia-Pacific Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Tetracyclines |
| 11.1.2. Penicillins |
| 11.1.3. Sulfonamides |
| 11.1.4. Macrolides |
| 11.1.5. Aminoglycosides |
| 11.1.6. Lincosamides |
| 11.1.7. Fluoroquinolones |
| 11.1.8. Cephalosporins |
| 11.1.9. Â Other Antimicrobials and Antibiotics |
| 11.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Premixes |
| 11.2.2. Oral Powder |
| 11.2.3. Oral Solution |
| 11.2.4. Injection |
| 11.2.5. Others |
| 11.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Food-Producing Animals |
| 11.3.2. Companion Animals |
| 11.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. China |
| 11.4.2. India |
| 11.4.3. Japan |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028 |
| 11.6. Asia-Pacific Animal Antibiotics and Antimicrobials Market Dynamics – Trends |
| 12. Latin America Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Tetracyclines |
| 12.1.2. Penicillins |
| 12.1.3. Sulfonamides |
| 12.1.4. Macrolides |
| 12.1.5. Aminoglycosides |
| 12.1.6. Lincosamides |
| 12.1.7. Fluoroquinolones |
| 12.1.8. Cephalosporins |
| 12.1.9. Â Other Antimicrobials and Antibiotics |
| 12.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Premixes |
| 12.2.2. Oral Powder |
| 12.2.3. Oral Solution |
| 12.2.4. Injection |
| 12.2.5. Others |
| 12.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Food-Producing Animals |
| 12.3.2. Companion Animals |
| 12.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Rest of Latin America |
| 12.5. Latin America Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028 |
| 12.6. Latin America Animal Antibiotics and Antimicrobials Market Dynamics – Trends |
| 13. Middle East and Africa Animal Antibiotics and Antimicrobials Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn) |
| 13.1. Product Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Tetracyclines |
| 13.1.2. Penicillins |
| 13.1.3. Sulfonamides |
| 13.1.4. Macrolides |
| 13.1.5. Aminoglycosides |
| 13.1.6. Lincosamides |
| 13.1.7. Fluoroquinolones |
| 13.1.8. Cephalosporins |
| 13.1.9. Â Other Antimicrobials and Antibiotics |
| 13.2. Mode of Delivery Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Premixes |
| 13.2.2. Oral Powder |
| 13.2.3. Oral Solution |
| 13.2.4. Injection |
| 13.2.5. Others |
| 13.3. Animal Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Food-Producing Animals |
| 13.3.2. Companion Animals |
| 13.4. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. South Africa |
| 13.4.3. Rest of MEA |
| 13.5. MEA Animal Antibiotics and Antimicrobials Market - Opportunity Analysis Index, By Product Type, Mode of Delivery, Animal Type, and Country, 2022-2028 |
| 13.6. MEA Animal Antibiotics and Antimicrobials Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Boehringer Ingelheim (Germany) |
| 14.2.2. Zoetis Inc. (US) |
| 14.2.3. Elanco Animal Health (US) |
| 14.2.4. Merck & Co. Inc (US) |
| 14.2.5. Phibro Animal Health (US) |
| 14.2.6. Virbac (France) |
| 14.2.7. Vetoquinol S.A. (France) |
| 14.2.8. Ceva Santé Animale (France) |
| 14.2.9. Dechra Pharmaceuticals Plc (UK) |
| 14.2.10. Kyoritsu Seiyaku (Japan) |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
- Boehringer Ingelheim (Germany)
- Zoetis Inc. (US)
- Elanco Animal Health (US)
- Merck & Co. Inc (US)
- Phibro Animal Health (US)
- Virbac (France)
- Vetoquinol S.A. (France)
- Ceva Santé Animale (France)
- Dechra Pharmaceuticals Plc (UK)
- Kyoritsu Seiyaku (Japan)